ASX has a few biotechs involved with wound healing - Avita (AVH) and Factor Therapeutics (FTT) which have not set the world on fire due to regulatory hurdles. This could be a problem for Qbiotics as it seems like they are early stage?
Plus the recent share trades seem to be at $0.40. No idea on how many shares are on issue so hard to say whether it is cheap based on market capitalisation?
- Forums
- Commodities
- Biotech 2017
ASX has a few biotechs involved with wound healing - Avita (AVH)...
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, MD & Executive Chairman
David Breeze
MD & Executive Chairman
SPONSORED BY The Market Online